Related Experiment Video
Updated: Jan 29, 2026
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Breaking barriers: feasibility of a cluster randomised trial evaluating an instrument for identifying and
Vera Logan1, David Hughes1, Adam Turner1
1Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK.
Objectives:
We aimed to investigate the feasibility of a cluster randomised controlled trial (RCT) of the ADRe Profile in UK primary care. The ADRe Profile is a patient monitoring system to identify and address adverse drug reactions (ADR) and ADR-related issues to pre-empt clinical deterioration.
Design:
A preliminary study to test the feasibility of an RCT.
Setting:
General practices (GPs) in South-West Wales, UK.
Participants:
20 patients aged >64 and prescribed >4 long-term medicines.
Interventions:
Participants reported their health-related problems using the ADRe-Profile. Participants completed the profile independently initially, then with researcher support, capturing vital signs, clinical observations and patient-reported symptoms.
Main Outcome Measures:
Feasibility was assessed based on recruitment, retention, adherence to protocols, potential for clinical impact and staff costs.
Results:
We recruited two GP practices (0.94% of 213 contacted), and 20 patients aged >64 (51.3% of those approached). Retention was 100%. ADRe Profiles had a 98.29% completion rate, identifying 289 clinical problems, including pain (16 of 20 patients), dyspnoea (10/20), dizziness (8/20), bleeding/bruising (7/20) and falls (4/20). Most problems (90%) and vital signs (78%) recorded on ADRe Profiles were absent from existing patient records. Researchers recommended further investigations (164 instances) and interventions (126 suggestions). Despite the potential for clinical benefits, engagement from clinicians was limited. Cost estimates for ADRe administration ranged from £40 to £73, within the funding available from Health and Care Research Wales.
Conclusions:
An RCT of the ADRe Profile was feasible, despite gatekeeping by clinicians. Recruitment of GP practices was challenging, with <1% of eligible practices participating. In contrast, patient recruitment and retention were successful. ADRe aligns with WHO patient safety goals and could improve healthcare by addressing ADR-related problems proactively in this vulnerable population.
Trial Registration Number:
NCT04663360; Pre-Results.
Related Concept Videos
01:27Allergic Drug Reactions
02:04Fixing Double-strand Breaks
01:23Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
01:17Drug Metabolism: Phase I Reactions
01:14Drug Metabolism: Phase II Reactions
01:11Clinical Trials: Overview